Product Information

CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.3828 per GM under NDC 45802038301. Its NADAC has been published 90 times since Oct 9, 2024.

CLINDAMYC-BNZ PEROX 1.2-3.75%

Clindamycin Phosphate and Benzoyl Peroxide
$2.3828per GM

Strength

37.5; 10 mg/g; mg/g

NDC

45802038301

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209610

On Market Since

9/20/2024

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 90 times since Oct 9, 2024, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3828 per GM
All-time high$5.9100 (Nov 13, 2024)
All-time low$2.3828 (Jun 17, 2026)
52-week high$4.6087
52-week low$2.3828
Median price$4.3364
Average price$4.2477
Largest weekly change-22.2% (Apr 22, 2026)
Weeks tracked90
Tracking sinceOct 9, 2024

Price History

1W

0.0%

1M

-2.7%

3M

-29.0%

6M

-47.3%

1Y

-42.6%

3Y

N/A

5Y

N/A

All

-53.3%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.3828 per GM (NDC 45802038301), effective Jun 24, 2026.

How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?

Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 53.3%. It has been tracked across 90 weekly CMS publications since Oct 9, 2024.

What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?

Since Oct 9, 2024, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $2.3828 (Jun 17, 2026) to a high of $5.9100 (Nov 13, 2024), with a median of $4.3364 per GM.

Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?

3 NADAC-published products share the same active ingredient, strength, and dosage form as CLINDAMYC-BNZ PEROX 1.2-3.75%, but none are currently priced below it.

Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?

CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 45802038301) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.